Radiomics of Brain MRI: Utility in Prediction of Metastatic Tumor Type.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 12 12 2018
medline: 27 11 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Purpose To investigate the feasibility of tumor type prediction with MRI radiomic image features of different brain metastases in a multiclass machine learning approach for patients with unknown primary lesion at the time of diagnosis. Materials and methods This single-center retrospective analysis included radiomic features of 658 brain metastases from T1-weighted contrast material-enhanced, T1-weighted nonenhanced, and fluid-attenuated inversion recovery (FLAIR) images in 189 patients (101 women, 88 men; mean age, 61 years; age range, 32-85 years). Images were acquired over a 9-year period (from September 2007 through December 2016) with different MRI units, reflecting heterogeneous image data. Included metastases originated from breast cancer (n = 143), small cell lung cancer (n = 151), non-small cell lung cancer (n = 225), gastrointestinal cancer (n = 50), and melanoma (n = 89). A total of 1423 quantitative image features and basic clinical data were evaluated by using random forest machine learning algorithms. Validation was performed with model-external fivefold cross validation. Comparative analysis of 10 randomly drawn cross-validation sets verified the stability of the results. The classifier performance was compared with predictions from a respective conventional reading by two radiologists. Results Areas under the receiver operating characteristic curve of the five-class problem ranged between 0.64 (for non-small cell lung cancer) and 0.82 (for melanoma); all P values were less than .01. Prediction performance of the classifier was superior to the radiologists' readings. Highest differences were observed for melanoma, with a 17-percentage-point gain in sensitivity compared with the sensitivity of both readers; P values were less than .02. Conclusion Quantitative features of routine brain MR images used in a machine learning classifier provided high discriminatory accuracy in predicting the tumor type of brain metastases. © RSNA, 2018 Online supplemental material is available for this article.

Identifiants

pubmed: 30526358
doi: 10.1148/radiol.2018180946
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-487

Auteurs

Helge C Kniep (HC)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Frederic Madesta (F)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Tanja Schneider (T)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Uta Hanning (U)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Michael H Schönfeld (MH)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Gerhard Schön (G)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Jens Fiehler (J)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Tobias Gauer (T)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

René Werner (R)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Susanne Gellissen (S)

From the Department of Diagnostic and Interventional Neuroradiology (H.C.K., T.S., U.H., M.H.S., J.F., S.G.), Department of Radiotherapy and Radiation Oncology (F.M., T.G.), Institute of Medical Biometry and Epidemiology (G.S.), and Institute of Computational Neuroscience (F.M., R.W.); University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH